ATC Abstracts

American Transplant Congress abstracts

  • Home
  • Meetings Archive
    • 2022 American Transplant Congress
    • 2021 American Transplant Congress
    • 2020 American Transplant Congress
    • 2019 American Transplant Congress
    • 2018 American Transplant Congress
    • 2017 American Transplant Congress
    • 2016 American Transplant Congress
    • 2015 American Transplant Congress
    • 2013 American Transplant Congress
  • Keyword Index
  • Resources
    • 2021 Resources
    • 2016 Resources
      • 2016 Welcome Letter
      • ATC 2016 Program Planning Committees
      • ASTS Council 2015-2016
      • AST Board of Directors 2015-2016
    • 2015 Resources
      • 2015 Welcome Letter
      • ATC 2015 Program Planning Committees
      • ASTS Council 2014-2015
      • AST Board of Directors 2014-2015
      • 2015 Conference Schedule
  • Search

Articles tagged "Kidney transplantation"

  • 2016 American Transplant Congress

    Long-Term Outcomes in Epstein-Barr Virus (EBV)-Positive Patients Receiving Belatacept (Bela) or Cyclosporine (CsA) in BENEFIT-EXT.

    S. Florman,1 J. Medina Pestana,2 M. del C Rial,3 L. Rostaing,4 D. Kuypers,5 A. Matas,6 T. Wekerle,7 J. Grinyó,8 U. Meier-Kriesche,9 M. Polinsky,9 H. Zhao,9 A. Durrbach.10

    1Mount Sinai Med Ctr, New York; 2Hosp do Rim, Sao Paulo, Brazil; 3Instituto de Nefrologia, Buenos Aires, Argentina; 4Univ Hosp, Toulouse, France; 5Univ Hosp Leuven, Leuven, Belgium; 6Univ of Minnesota, Minneaopolis; 7Med Univ of Vienna, Vienna, Austria; 8Univ Hosp Bellvitge, Barcelona, Spain; 9BMS, Lawrenceville; 10Univ Hôpital of Bicêtre, Le Kremlin-Bicêtre, France.

    At 7 yrs post transplant in BENEFIT-EXT (NCT00114777), bela-treated pts had similar graft survival and improved renal function vs CsA-treated pts. Bela is indicated for…
  • 2016 American Transplant Congress

    Using 3D Printing in Complex Pediatric Renal Transplantation.

    P. Chandak,1 N. Byrne,2 N. Karunanithy,3 C. Callaghan,1 I. Mushtaq,4 S. Marks,4 J. Stajonovic,1 Z. Ahmed,1 N. Kessaris,1 N. Mamode.1

    1Transplantation, Guy's, Evelina & Great Ormond Street, London, United Kingdom; 2Imaging Sciences, King's College London, London, United Kingdom; 3Interventional Radiology, Guy's, London, United Kingdom; 4Paediatric Nephrology and Urology, Great Ormond Street, London, United Kingdom.

    Introduction:Structural complexities can render graft implantation infeasible in small paediatric recipients. Surgical decision-making currently relies on 3D medical imaging which limits evaluation of structures by…
  • 2016 American Transplant Congress

    Increased Gene Expression of TGF-β in Peripheral Blood Mononuclear Cells from Renal Transplant Patients with Polyomavirus BK Viremi.

    W. Yin,1 M. Lu.2

    1Surgery, School of Medicine, Tzu Chi University, Hualien, Taiwan, Division of General Surgery, Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Chia-I, Dalin, Taiwan; 2Allergy, Immunology and Rheumatology, School of Medicine, Tzu Chi University, Hualien, Taiwan, Division of Allergy, Immunology and Rheumatology, Dalin Tzu Chi Hospital, Buddhist Tzu Chi Medical Foundation, Chia-I, Dalin, Taiwan.

    We aimed to investigate the roles of cytokines during polyomavirus BK (BKV) reactivation in renal transplant patients. Forty-eight renal allograft recipients were enrolled in this…
  • 2016 American Transplant Congress

    Subclinical Cytomegalovirus Viraemia in Renal Transplant Recipients.

    K. Barker,1 N. Cook,1 P. Kevan,2 I. Frank.1

    1Renal Transplant Unit, Austin Hospital, Melbourne, Victoria, Australia; 2Renal Unit, Monash Medical Centre, Melbourne, Victoria, Australia.

    Background: Studies suggest low-level cytomegalovirus (CMV) viraemia, detected with sensitive molecular assays, may lead to poorer graft outcomes following renal transplantation.Aims: Investigate the incidence, outcomes,…
  • 2016 American Transplant Congress

    Significant Association of Innate Immune Related Genes Polymorphism on Infectious Complications Following Early Post Renal Transplantation phase.

    L. Das, K. Ide, Y. Tanaka, S. Shimizu, N. Tanimine, S. Verma, H. Ohdan.

    Department of Gastroenrological and Transplant Surgery, Hiroshima University, Hiroshima, Japan.

    ObjectiveInfectious complication is the leading cause of graft dysfunction and patient loss after renal transplantation (RT). In the early post-transplant phase where acquired immunity is…
  • 2016 American Transplant Congress

    Evaluation of Patient-Reported Nonadherence with Tacrolimus Level Variability in Renal Transplant Recipients.

    N. Parrish,1 T. Kaiser,2 A. McCann,1 J. Aladimi,2 J. Harris,3 A. Govil,2 B. Abu Jawdeh,2 G. Mogilishetty,2 R. Alloway,2 E. Woodle.2

    1Pharmacy Services, University of Cincinnati Medical Center, Cincinnati, OH; 2Medicine, University of Cincinnati, Cincinnati, OH; 3Transplant, University of Cincinnati Medical Center, Cincinnati, OH.

    Medication nonadherence (NA) continues to be a major cause of graft loss post-transplant. Several methods for prospective adherence monitoring have been described including patient interview…
  • 2016 American Transplant Congress

    Impact of the Kidney Allocation System with Deceased Donor Kidney Transplantation: A Single Center Experience.

    A. Agarwal, W. Ally, D. Maluf, S. Pelletier, K. Brayman.

    University of Virginia Health System, Charlottesville, VA.

    Background: In December 2014, UNOS implemented broad sweeping changes in the new Kidney Allocation System (KAS). Recent summary reports by UNOS suggest that nationally, key…
  • 2016 American Transplant Congress

    Role of Cardiac Evaluation and Management in Kidney and Liver Transplant Candidates.

    W. Bannister, C. Wu, M. Schnitzler, A. Bonagura, B. Laihinen, F. Irwin.

    Complex Medical Conditions, Optum, UnitedHealth Group, Eden Prairie, MN; Surgery, St Louis University, St Louis, MO.

    Cardiac evaluation and risk stratification prior to kidney and liver transplantation can be critical to patient selection and outcomes.Methods: We assessed the impact of cardiac…
  • 2016 American Transplant Congress

    Impact of Morbid Obesity on Breakthrough CMV Infection in Kidney Transplant Recipients.

    S. Strout, N. Pilch, T. Veasey, R. Miller, J. Fleming, H. Meadows, C. Mardis, B. Mardis, P. Baliga, K. Chavin, D. Taber.

    Medical University of South Carolina, Charleston, SC.

    Purpose: The aim of this study was to assess the impact of obesity on risk for cytomegalovirus (CMV) infection after kidney transplantation as well as…
  • 2016 American Transplant Congress

    Survival Benefit of Living Donor ABOi Kidney Transplantation.

    A. Massie, B. Lonze, S. Anjum, X. Luo, D. Segev.

    JHU, Baltimore.

    A recent editorial in AJT characterized ABOi transplants as "Twice as Expensive, Half as Good" and challenged the ABOi community to evaluate survival benefit of…
  • « Previous Page
  • 1
  • …
  • 427
  • 428
  • 429
  • 430
  • 431
  • …
  • 531
  • Next Page »

Visit Our Partner Sites

American Transplant Congress (ATC)

Visit the official site for the American Transplant Congress »

American Journal of Transplantation

The official publication for the American Society of Transplantation (AST) and the American Society of Transplant Surgeons (ASTS) »

American Society of Transplantation (AST)

An organization of more than 3000 professionals dedicated to advancing the field of transplantation. »

American Society of Transplant Surgeons (ASTS)

The society represents approximately 1,800 professionals dedicated to excellence in transplantation surgery. »

Copyright © 2013-2025 by American Society of Transplantation and the American Society of Transplant Surgeons. All rights reserved.

Privacy Policy | Terms of Use | Cookie Preferences